Scpharmaceuticals Inc Revenue per Employee (SCPH), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Scpharmaceuticals Inc   (NASDAQ: SCPH)
 

Scpharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Scpharmaceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 11,421, below the company average number of $6,982.
Within the Healthcare sector Employees of 450 other companies have achieved higher revenue per employee. While Scpharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 2787 to 2872. Scpharmaceuticals Inc has 4,375 employees.


What is Sales per Employee Ratio?







SCPH Revenue per Employee (Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
Y / Y Revenue Change 99.17 % 92.59 % 99.31 % 164.12 % 391.7 %
Sales per Employee (TTM) $ 11,421 9,596 8,304 6,921 5,497
SCPH's Total Ranking # 2872 # 2787 # 2836 # 3451 # 2987
Seq. Revenue Change 36.5 % -3.28 % 21.18 % 24.48 % 31.99 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 166
Healthcare Sector # 451
Overall Market # 2872

Revenue per Employee Statistics
High Average Low
$ 11,421 $ 6,982 $ 3,107
(Jun 30 2025)   (Dec 31 2023)



Financial Statements
Scpharmaceuticals Inc 's Revenue MRQ $ 16 Millions Visit SCPH's Income Statement
Scpharmaceuticals Inc 's Revenues TTM $ 50 Millions Visit SCPH's aggregate revenue growth
What are SCPH's Sales? Visit SCPH's Sales by Segment




Other Ratios
Scpharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SCPH's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SCPH's Competitors
Revenue per Employee for SCPH's Suppliers
Revenue per Employee for SCPH's Customers

You may also want to know
SCPH's Sales Growth Rates SCPH's Pe Price to earnings ratio SCPH's Receivables Turnover Ratio SCPH's Stock Quote
SCPH's Net Income Growth Rates SCPH's Ps Price to Sales ratio SCPH's Sales per Employee SCPH's Asset Turnover Ratio
SCPH's Net Margin SCPH's Pb Price to Book ratio SCPH's Financial Strength Ratios SCPH's Dividend Payout Ratio
Date modified: 2026-08-29T17:39:09+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2025Number of Employees Jun 30 2025
China Pharma Holdings Inc  19,892.31 $ 4.396  Million 221 
Precision Biosciences Inc  18,544.12 $ 1.261  Million 68 
Volitionrx Limited  17,590.03 $ 1.319  Million 75 
Cardiff Oncology Inc   17,580.65 $ 0.545  Million 31 
Vistagen Therapeutics Inc   15,756.10 $ 0.646  Million 41 
Solana Company  14,047.62 $ 0.295  Million 21 
Cartesian Therapeutics Inc   13,680.00 $ 1.026  Million 75 
Biolinerx Ltd   12,666.67 $ 0.304  Million 24 
Ataibeckley Inc   11,430.69 $ 2.309  Million 202 
Scpharmaceuticals Inc   11,421.49 $ 49.969  Million 4,375 
Northwest Biotherapeutics Inc  10,419.05 $ 1.094  Million 105 
Skinvisible Inc   10,000.00 $ 0.020  Million
Co diagnostics Inc   8,727.42 $ 1.004  Million 115 
Aim Immunotech Inc   5,761.90 $ 0.121  Million 21 
Aclarion Inc   5,722.64 $ 0.063  Million 11 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.